Trade Summary

3 days ago, Third Rock Ventures V, L.P., serving as 10% owner Owner at Rapport Therapeutics, Inc. (RAPP), sold 18,572 shares at $40.05 per share, for a total transaction value of $743,752.88. Following this transaction, Third Rock Ventures V, L.P. now holds 6,280,525 shares of RAPP.

This sale represents a 0.29% decrease in Third Rock Ventures V, L.P.'s stake in the company.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:15 PM ET, 2 days after the trade was made.

Rapport Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.